C. Pharmaceutics Flashcards

1
Q

for doses to be effective

A

Deposit in appropriate region
right quantity
cross barriers and defence mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

inertial impaction mechanism

A

bigger particles deposit quickly in the upper airways due to higher inertia
scales with mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

sedimentation mechanism

A

gravity can pull particles to airway surface

scales with mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

aerodynamic diameter

A

a particle can be more than 10 microns but behave as 3 microns, due to less daer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

interception mechanism

A

particles contact airway surface due to the size/shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Respirable fraction

A

percentage of particle that are less than 5 um, hence likely to be deposited.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sizing of particles in inhaled products

A

Microscopy (labour intensive)
laser diffraction
aerosizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Microscopy

A

electron or optical
need to be aware of irregular 3d particles when observing
good observation for shape
difference between projected area diameter and projected perimeter diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

laser diffraction

A

measures light diffraction pattern - size

assumes spherical particle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

aerosizer

A

measures time particle needs to move through laser
small particle - faster
0.2-700 microns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

impaction methods of measuring aerodynamic diameter

A

predict site of deposition in lung

using inertial impaction mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Twin liquid impinger in seperating large and small particles cut off-6.4 microns

A

two stages
cheap, simple
BP accepted but not USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Andersen cascade impactor

or Next generation impactor

A

8 stages
size distribution information
labour intensive
accepted by BP and USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Eye drug delivery lecture

A

anterior and posterior segments completely separated.

tear film three layers, lipid, aqueous, mucin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

if disease is before cornea can be treated with eyedrops

A

behind cornea only 1-5% can be absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

reason why low absorption in anterior segment

A
tear drainage (drug diluted)
absorption into system circulation 
protein binding in tear film
corneal barrier (drug has to have correct hydro-lipo philicity)
17
Q

Eye drops

A
solution- free of particles
suspension- particles less than 50 microns
ph 7.4
isotonic
sterile using preservatives max 10 ml
18
Q

eye ointments

A

dispersed in semi-solid greasy base
max 50 micron particles
no preservatives as no water

19
Q

Nasal drug delivery lecture

A

Regions: Vestibule, Atrium, Turbinates, olfactory, nasopharynx
Turbinates (warm, humidify, filter air) increase SA

20
Q

Respiratory epithelium

A

ciliated and non ciliated cells, goblet, basal cells
mucus
vascularised
large SA - rapid absorption

21
Q

advantages in nasal delivery

A
easy acces
non invasive
avoid GI tract
rapid absorption
easy formulation
22
Q

limitations of nasal delivery

A

small cavity
mucociliary clearance - 15-20 min
high cyp450 and proteases
systemic side effects

23
Q

Nasal sprays

A

particles > 50 microns
easier to administer
must be: aqueous, isotonic, physiological pH.

24
Q

INHALERS 3

A

nEBULISER - aqueous solution
Pressurised meted dose inhalers (pMDI) liquified gas
Dry powder inhalers

25
Nebulisers
Jet: air forced through a narrow hole | ultrasonic (portable): piezoelectric crystals
26
Nebuliseer advantage
``` aqueous (simple for soluble drugs) no hand lung coordination large doses inhalaiton manoeuvre not needed low cost ```
27
Disadvantages nebuliser
not protable yet long time low efficiency (10% reaches lungs) micorbial contamination
28
`pMDI
inhaler label container: strong(pressure), robust, light, inert. propellant: liquid under pressure - gas in atmospheric, vapour pressure needs to be constant, nonflammable, inert. Hydro fluoroalkanes (HFA)
29
drug aspects
dose 5microns - 5 mg | particle size reduction needed - to deposit
30
problems with suspensios
sedimentation flocculation (reversible) caking ostwald ripening
31
pMDI advantage
``` portable multidose consistent formation and operation for all typees inexpensive dose uniformity ```
32
pMDI Disadvantages
``` no breath actuation low lung deposition no dose counter on most low doses priming before use ```
33
DPIs
drug more stable in dry form rather than in suspension | dose not constant - vary patient to patient
34
main issues
<5 microns are cohesive, hard to separate | moisture increase agglomeration
35
types os DPI
unit multiple unit reservoir
36
types of DPI
unit multiple unit reservoir
37
Disadvantages
Breath actuated(depend on patient effort) different designs humidity affected expensive